Clinical Trial

Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients

Name: Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients — clinical trial record (NCT07074457)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of chidamide combined with brentuximab vedotin regimen for CD30 positive PTCL patients who are unfit for chemotherapy.

Trial Details

NCT Number	NCT07074457
Lead Sponsor	The First Affiliated Hospital of Soochow University
Conditions	CD30+ Peripheral T-cell Lymphoma
Enrollment	47 participants
Start Date	2024-11-01
Primary Completion	2028-08-01 (estimated)
Study Completion	2028-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-20